{
    "relation": [
        [
            "Feature key",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti"
        ],
        [
            "Position(s)",
            "138 \u2013 138",
            "309 \u2013 309",
            "338 \u2013 338",
            "545 \u2013 545",
            "697 \u2013 697",
            "699 \u2013 699",
            "706 \u2013 706",
            "718 \u2013 718"
        ],
        [
            "Length",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1"
        ],
        [
            "Description",
            "L \u2192 F in a lung adenocarcinoma sample; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.18 \"Patterns of somatic mutation in human cancer genomes.\" Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. , Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R. Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] PHE-138.",
            "G \u2192 R.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.5 \"Full length truncated TrkB sequence identified in a screen for genes regulated by ischemic preconditioning.\" Steinbeck J.A., Thomsen S., Wessig J., Leypoldt F., Lewerenz J., Methner A. Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TRKB-T1), VARIANT ARG-309.",
            "N \u2192 Y. Corresponds to variant rs1047856 [ dbSNP | Ensembl ].",
            "G \u2192 V. Corresponds to variant rs1075108 [ dbSNP | Ensembl ].",
            "M \u2192 I in a lung carcinoma sample; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.19 \"Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.\" Marchetti A., Felicioni L., Pelosi G., Del Grammastro M., Fumagalli C., Sciarrotta M., Malatesta S., Chella A., Barassi F., Mucilli F., Camplese P., D'Antuono T., Sacco R., Buttitta F. Hum. Mutat. 29:609-616(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ILE-697; GLY-699 AND CYS-718.",
            "R \u2192 G in a lung carcinoma sample; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.19 \"Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.\" Marchetti A., Felicioni L., Pelosi G., Del Grammastro M., Fumagalli C., Sciarrotta M., Malatesta S., Chella A., Barassi F., Mucilli F., Camplese P., D'Antuono T., Sacco R., Buttitta F. Hum. Mutat. 29:609-616(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ILE-697; GLY-699 AND CYS-718.",
            "Y \u2192 C in OBHD; expressed normally on the cell surface; results in markedly impaired ligand-induced phosphorylation as well as impaired downstream MAPK1 phosphorylation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.17 \"A de novo mutation affecting human TrkB associated with severe obesity and developmental delay.\" Yeo G.S., Connie Hung C.C., Rochford J., Keogh J., Gray J., Sivaramakrishnan S., O'Rahilly S., Farooqi I.S. Nat. Neurosci. 7:1187-1189(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT OBHD CYS-706, CHARACTERIZATION OF VARIANT OBHD CYS-706, FUNCTION AS A BDNF-ACTIVATED RECEPTOR, PHOSPHORYLATION, SUBCELLULAR LOCATION.",
            "R \u2192 C in a lung carcinoma sample; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.19 \"Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.\" Marchetti A., Felicioni L., Pelosi G., Del Grammastro M., Fumagalli C., Sciarrotta M., Malatesta S., Chella A., Barassi F., Mucilli F., Camplese P., D'Antuono T., Sacco R., Buttitta F. Hum. Mutat. 29:609-616(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ILE-697; GLY-699 AND CYS-718."
        ],
        [
            "Graphical view",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "Feature identifier",
            "VAR_041470",
            "VAR_016320",
            "VAR_011973",
            "VAR_049715",
            "VAR_046518",
            "VAR_046519",
            "VAR_065890",
            "VAR_046520"
        ],
        [
            "Actions",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ]
    ],
    "pageTitle": "NTRK2 - BDNF/NT-3 growth factors receptor precursor - Homo sapiens (Human)",
    "title": "",
    "url": "http://www.uniprot.org/uniprot/Q16620",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988312.76/warc/CC-MAIN-20150728002308-00110-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 808163899,
    "recordOffset": 808092774,
    "tableOrientation": "HORIZONTAL",
    "lastModified": "Wed, 22 Jul 2015 00:00:00 GMT",
    "textBeforeTable": "Natural variant BLASTProtParamProtScaleCompute pI/MWPeptideMassPeptideCutterGO <p>The checksum is a form of redundancy check that is calculated from the sequence. It is useful for tracking sequence updates.</p> <p>It should be noted that while, in theory, two different sequences could have the same checksum value, the likelihood that this would happen is extremely low.</p> <p>However UniProtKB may contain entries with identical sequences in case of multiple genes (paralogs).</p> <p>The checksum is computed as the sequence 64-bit Cyclic Redundancy Check value (CRC64) using the generator polynomial: x<sup>64</sup> + x<sup>4</sup> + x<sup>3</sup> + x + 1. The algorithm is described in the ISO 3309 standard. </p> <p class=\"publication\">Press W.H., Flannery B.P., Teukolsky S.A. and Vetterling W.T.<br /> <strong>Cyclic redundancy and other checksums</strong><br /> <a href=\"http://www.nrbook.com/b/bookcpdf.php\">Numerical recipes in C 2nd ed., pp896-902, Cambridge University Press (1993)</a>)</p> Checksum:i64C146AAB494744E 35,332 Mass (Da): 321 Length: Show \u00bb  10 20 30 40 50 MWIKTLQEAK SSPDTQDLYC LNESSKNIPL ANLQIPNCGL PSANLAAPNL  60 70 80 90 100 TVEEGKSITL SCSVAGDPVP NMYWDVGNLV SKHMNETSHT QGSLRITNIS  110 120 130 140 150 SDDSGKQISC VAENLVGEDQ DSVNLTVHFA PTITFLESPT SDHHWCIPFT  160 170 180 190 200 VKGNPKPALQ WFYNGAILNE SKYICTKIHV TNHTEYHGCL QLDNPTHMNN  210 220 230 240 250 GDYTLIAKNE",
    "textAfterTable": "Alternative sequence Feature key Position(s) Length Description Graphical view Feature identifier Actions <p>Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.</p><p><a href='../manual/var_seq' target='_top'>More...</a></p>Alternative sequencei 1\u00a0\u2013\u00a0156 156 Missing in isoform TrkB-N-T1. 1 Publication <p>Manually curated information that is based on statements in scientific articles for which there is no experimental support.</p> <p><a href=\"/manual/evidences#ECO:0000303\">More\u2026</a></p> Manual assertion based on opinion ini Ref.6 \"Complete sequencing and characterization of 21,243 full-length human cDNAs.\" Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}